Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
Formulary comparisons
-
We have an eFile (from 2010) the has a chart that compares coverage for products in each of the provinces. The chart has a checkmark to indicate that it is listed (with restrictions) and and "x" to indicate that the product is not listed. Can I use a similar treatment (checkmark and x) in a piece we am creating now or have the rules changed?
-
Moved from PAAB Code by
Jennifer Carroll
-
Good morning @gmc
PAAB has issued advisories and guidance regarding formulary claims since 2010. In addition, we have received feedback from formularies regarding the presentation of formulary coverage in APS since then. The 2010 eFile may not reflect the more recent information and should not be used as precedent. We suggest submitting for an opinion should there be more specific questions regarding the proposed project.